Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression-Reference-Cited by-同舟云学术

Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression

Published:2020-03 Issue:6 Volume:105 Page:975-991.e7
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Bai Bing,Wang Xusheng,Li Yuxin,Chen Ping-Chung,Yu Kaiwen,Dey Kaushik Kumar,Yarbro Jay M.,Han Xian,Lutz Brianna M.,Rao Shuquan,Jiao Yun,Sifford Jeffrey M.,Han Jonghee,Wang Minghui,Tan Haiyan,Shaw Timothy I.,Cho Ji-Hoon,Zhou Suiping,Wang Hong,Niu Mingming,Mancieri Ariana,Messler Kaitlynn A.,Sun Xiaojun,Wu Zhiping,Pagala Vishwajeeth,High Anthony A.,Bi Wenjian,Zhang Hui,Chi Hongbo,Haroutunian Vahram,Zhang Bin,Beach Thomas G.,Yu Gang,Peng Junmin

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

General Neuroscience

Reference103 articles.

1. Mass-spectrometric exploration of proteome structure and function;Aebersold;Nature,2016

2. Gene prioritization through genomic data fusion;Aerts;Nat. Biotechnol.,2006

3. Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases;Allen;Sci. Data,2016

4. Microarray data analysis: from disarray to consolidation and consensus;Allison;Nat. Rev. Genet.,2006

5. Next-generation proteomics: towards an integrative view of proteome dynamics;Altelaar;Nat. Rev. Genet.,2013

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer’s disease biomarkers;Journal of Neuroscience Methods;2024-11

2. Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients;Journal of Alzheimer's Disease;2024-09-10

3. Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies;Molecular Neurobiology;2024-09-06

4. The role of N6-methyladenosine modification in neurodegenerative diseases;Ageing and Neurodegenerative Diseases;2024-09-05

5. Molecular Signatures of Neurodegenerative Diseases Identified by Proteomic and Phosphoproteomic Analyses in Aging Mouse Brain;Molecular & Cellular Proteomics;2024-09